• 1
    Young JL, Pollack ES. The incidence of cancer in the United States. In: SchottenfeldD, FraumeniJF, editors. Cancer epidemiology and prevention. Philadelphia: W.B. Saunders Company, 1982: 13865.
  • 2
    Axtell LM, Myers MH. Contrasts in survival of black and white cancer patients: 1960 to 1973. J Nail Cancer Inst 1978; 60: 120915.
  • 3
    Burdick D, Chantry F. New York Surgical Society survey on breast cancer. Cancer. 1954; 7: 4753.
  • 4
    White JE, Enterline JP, Adam Z, Moore RM Jr. Cancer among blacks in the United States: recognizing the problem. In: MettlinC, MurphyGP, editors. Cancer among black populations. New York: Alan R. Liss, 1981: 3553.
  • 5
    Lewison EF, Montague AC, Kuller L. Breast cancer treated at the Johns Hopkins Hospital 1951–1956. Cancer 1966; 19: 135964.
  • 6
    Miller BA, Feuer EJ, Hankey BF. The increasing incidence of breast cancer since 1982: relevance of early detection. Cancer Causes Control 1991; 2: 6774.
  • 7
    Chen VW, Pelayo C, Kurman RJ, We XC, Eley W, Austin W, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev 1994; 3: 12735.
  • 8
    Young JL, Ries LG, Pollack ES. Cancer patient survival among ethnic groups in the United States. J Natl Cancer Inst 1984; 73: 34152.
  • 9
    Hunter CP, Redmond CK, Chen VW, Austin DF, Greenberg RS, Correa P, et al. Breast cancer: factors associated with stage at diagnosis in black and white women. Black/White Cancer Survival Study Group. J Natl Cancer Inst 1993; 85: 112937.
  • 10
    Farley TA, Flannery JT. Late-stage diagnosis of breast cancer in women of lower socioeconomic status: public health implications. Am J Public Health 1989; 79 (11): 150812.
  • 11
    Wells BL, Horn JW. Stage at diagnosis in breast cancer: race and socioeconomic factors. Am J Public Health 1992; 82: 13835.
  • 12
    Cella DF., Orav EJ., Kornblith AB., Holland JC., Silberfarb PM., Lee KW. Socioeconomic status and cancer survival. J Clin Oncol 1991; 9 (8): 15009.
  • 13
    Lipworth L, Abelin T, Connelly R. Socioeconomic factors in the prognosis of cancer patients. J Chron Dis 1970; 23: 10516.
  • 14
    Vernon SW, Tilley BC, Neale AV, Steinfeldt L, et al. Ethnicity, survival and delay in seeking treatment for symptoms of breast cancer. Cancer 1985; 55: 156771.
  • 15
    Myers MH. Survival from cancer by blacks and whites. MettlinC, MurphyGP, editors. Cancer among black populations. New York: A. R. Liss., 1981: 15265.
  • 16
    McWhorter WP, Mayer WJ. Black/white differences in type of initial breast cancer treatment and implications for survival. Am J Public Health 1987; 77: 15157.
  • 17
    Owenby HE, Frerixk J, Russo J, Brook SC, Swanson GM, Heppner GH, et al. Racial differences in breast cancer patients. J Natl Cancer Inst 1985; 75: 5560.
  • 18
    Mohla S, Sampson CC, Khan T, Enterline JP, Leffall L Jr., White J. Estrogen and progesterone receptors in breast cancer in lack Americans. Cancer 1982; 50: 5529.
  • 19
    Bondy ML, Spitz MR, Halani S, Fueger JJ, Vogel VG. Low incidence of familial breast cancer among Hispanic women. Cancer Causes Control 1992; 3: 37782.
  • 20
    Five year relative survival rates by primary site and racial/ethnic group, SEER Program, 19731981. Bethesda (MD): Springer National Cancer Institute. Cancer among blacks and other minorities statistical profiles. 1986 DHEW Publ. No.:(NCI) 86–278S.
  • 21
    Daly M, Osborne C, Clark G: Mexican-American breast cancer patients have a worse prognosis. Proc ASCA 1983; 2: 5.
  • 22
    Elledge RM, Clark GM, Chamness GC, Osborne CK. Tumor biologic factors and breast cancer prognosis among white, Hispanic, and black women in the United States. J Natl Cancer Inst 1994; 886: 70512.
  • 23
    American Joint Committee on Cancer: manual for staging of cancer. 4th ed. In BeahrsOH, HensonDE, HutterRVP, KennedyBJ, editors. Philadelphia JB: Lippincott Co 1992: 14954.
  • 24
    Bast R, Fenoglio-Preiser CM, Ozer H, Sidransky D. Clinical applications of tumor markers. Contemp Ob/Gyn 1993; 38: 5972.
  • 25
    Yasasever V, Karaloglu D, Erturk N, Dalay N. Diagnostic value of the tumor markers in breast cancer. Eur J Gynaecol Oncol 1994; 15: 336.
  • 26
    Patel S, Baxi BR, Adhvaryu SG, Balar DB. Individual and combined usefulness of lipid associated sialic acid, mucoid proteins and hexoses as tumor markers in breast carcinoma. Cancer Lett 1990; 51: 2038.
  • 27
    Fallenius A, Franzén SA, Auer GU. Predictive value of nuclear DNA content in breast cancer in relation to clinical and morphologic factors. Cancer 1988; 62: 52130.
  • 28
    Wintzer H, Zipfel I, Schulte-Mönting J, Von Kleist S. Ki-67 immunostaining in breast tumors and its relationship to prognosis. Cancer 1991; 67: 4218.
  • 29
    Thorpe S. Estrogen and progesterone receptor determinations in breast cancer. Acta Oncol 1987; 27: 119.
  • 30
    Salmon D, et al. Studies of the Her2/neu proto-oncogene in human breast and ovarian cancer. Science 1989; 244: 70712.
  • 31
    Sainsbury J, et al. Epidermal growth factor receptor as a predictor of early recurrence and death from breast cancer. Lancet 131 1987; 13981402.
  • 32
    Lee J, Kolonel LN, Hinds MW. Relative merits of the weight-corrected-for-height indices. Am J Clin Nutr 34: 25219.
  • 33
    BrayG, editor. Obesity in America. Bethesda (MD): US Department of Health Education and Welfare, 1979. NIH Publication No.:79-359: 6.
  • 34
    Gion M, Mione R, Didtadi R, Fasan S, Palline A, Bruscognin G. Evaluation of CA 15-3 serum levels in breast cancer patients. J Nucl Med 1986; 30: 306.
  • 35
    Hayes DF, Zurawski VR, Kufe DW. Comparison of circulating CA 15-3 and CEA levels in patients with breast cancer. J Clin Oncol 1986; 4: 154250.
  • 36
    Safi F, Kohler I, Rottinger R, Beger H. The value of the tumor marker CA 15-3 in diagnosing and monitoring breast cancer. A comparative study with carcinoembryonic antigen. Cancer 1991; 68: 57482.
  • 37
    Greenberg ER, Vessey MP, McPherson K, Doll R, Yeates D. Body size and survival in premenopausal breast cancer. Br J Cancer 1985; 5: 6917.
  • 38
    Austin H, Cole P, Wynder E. Breast cancer in black American women. Int J Cancer 1979; 24: 5414.
  • 39
    Schatzkin A, Palmer JR, Rosenberg L, Helmrich SP, Miller DR, Kaufman DW, et al. Risk factors for breast cancer in black women. J Natl Cancer Inst 1987; 78: 2137.
  • 40
    Burke GI, Savage PJ, Manolio TA, Sprafka JM, Wagenkrecht LE, Sidney S, et al. Coorelates of obesity in young black and white women: the CARDIA Study. Ant J Public Health 1993; 82: 16215.
  • 41
    Zumoff B, Dasgupta I. Relationship between body weight and the incidence of positive axillary nodes at mastectomy for breast cancer. J Surg Oncol 1983; 22: 21720.
  • 42
    Mohle-Boetani JC, Grosser S, Whittemore AS, Malec M, Kampert JB, Paffenbarger RS. Body size, reproductive factors, and breast cancer survival. Prev Med 1988; 123: 76774.
  • 43
    Ingram DM, Huyang HY, Catchpole NM, Roberts A. Do big breasts disadvantage women with breast cancer? Aust N Z J Surg 1989; 59: 1157.
  • 44
    Stoll BA, Secreto G. New hormone-related markers of high risk to breast cancer. Ann Oncol 1992; 3: 4258.
  • 45
    Kirschner MA. Obesity, androgens, oestrogens and cancer risk. Cancer Res 1982; 42(Suppl): 32815.
  • 46
    Millar WJ, Stephens T. Social status and health risks in Canadian adults: 1985 and 1991. Health Rep 1993; 5: 14356.
  • 47
    Allan JD, Mayo K, Michel Y. Body size values of white and black women. Res Nurs Health 1993; 16:323333.
  • 48
    Lackland DT, Dunbar JB, Keil JE, Knapp RG, O'Brien PH. Breast cancer screening in a biracial community: the Charleston tricounty experience. South Med J 1991; 84: 8626.
  • 49
    Caplan LS, Wells BL, Haynes S. Breast cancer screening among older racial/ethnic minorities and whites: barriers to early detection. J Gerontol 1992; 47: Spec No: 10110.
  • 50
    Vernon SE, Vogel VG, Halabi S, Jackson GI, Lundy RO, Peters GN. Breast cancer screening behaviors and attitudes in three racial/ethnic groups. Cancer 1992; 69: 16574.